Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches-Reference-Cited by-同舟云学术

Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches

Published:2018 Issue:10 Volume:8 Page:5286-5297
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Kang De¹²³⁴⁵^ORCID,Pang Xiaocong¹²³⁴⁵,Lian Wenwen¹²³⁴⁵,Xu Lvjie¹²³⁴⁵,Wang Jinhua¹²³⁴⁵,Jia Hao¹²³⁴⁵,Zhang Baoyue¹²³⁴⁵,Liu Ai-Lin¹²³⁴⁵,Du Guan-Hua¹²³⁴⁵

Affiliation:

1. Institute of Materia Medica

2. Chinese Academy of Medical Sciences

3. Peking Union Medical College

4. Beijing 100050

5. China

Abstract

The high morbidity and mortality of cancer make it one of the leading causes of global death, thus it is an urgent need to develop effective drugs for cancer therapy.

Funder

CAMS

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2018/RA/C7RA12259D

Reference49 articles.

1. Cancer statistics, 2017

2. Cancer heterogeneity: origins and implications for genetic association studies

3. Hallmarks of Cancer: The Next Generation

4. Angiogenesis as a therapeutic target

5. Angiogenesis: A Target for Cancer Therapy

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive applications of the artificial intelligence technology in new drug research and development;Health Information Science and Systems;2024-08-08

2. Identification of novel covalent JAK3 inhibitors through consensus scoring virtual screening: integration of common feature pharmacophore and covalent docking;Molecular Diversity;2024-07-15

3. From Deep Learning to the Discovery of Promising VEGFR‐2 Inhibitors;ChemMedChem;2024-06-20

4. Recent advances in the development of DprE1 inhibitors using AI/CADD approaches;Drug Discovery Today;2024-06

5. Application of Support Vector Machine Classification Model to Identification of Vascular Endothelial Growth Factor Receptor Inhibitors;Advanced Biomedical Research;2024-06